Tobacco smoking differently influences cell types of the innate and adaptive immune system—indications from CpG site methylation

Mario Bauer, Beate Fink, Loreen Thürmann, Markus Eszlinger, Gunda Herberth, Irina LehmannClinical 2016 · DOI

Abstract Studying cell type-specific methylation changes provides helpful information regarding the biological relevance of epigenetic modifications. Here, we could show that smoking differently affects both cells of the innate and adaptive immune systems.

Introduction

For years, epigenetic research has utilized "whole blood" as a proxy to investigate how environmental toxins, such as tobacco smoke, impact DNA methylation. While these studies have successfully identified numerous CpG sites—regions where a cytosine is followed by a guanine—that undergo hypomethylation in smokers, the underlying biological significance has remained unclear.

The primary challenge lies in the composition of blood, which is a complex mixture of various cell types, including neutrophils, lymphocytes, and monocytes. A detected change in whole blood could represent a subtle shift across all cells or a profound modification within a single specific cell type. This study aims to deconstruct this cellular mixture to identify which immune cells are the primary responders to tobacco smoke and whether these epigenetic shifts serve as biomarkers of "disturbed homeostasis."

Methods

To move beyond bulk analysis, researchers fractionated blood samples from healthy volunteers (smokers and non-smokers) into distinct populations, including granulocytes (innate immune system), peripheral blood mononuclear cells (PBMCs), and sorted CD3+ T-cells (adaptive immune system), specifically focusing on GPR15 expression.

The methodology integrated several techniques:

  • Flow Cytometry: For sorting and quantifying specific cell populations.
  • Pyrosequencing: To measure DNA methylation at seven high-interest CpG sites, including AHRR, F2RL3, and GPR15.
  • qPCR: To evaluate whether epigenetic changes correlated with gene expression levels.
  • In vitro exposure: Treating cells with cigarette smoke extract (CSE) to attempt replication of effects in a controlled environment.

Findings were validated using three independent adult cohorts (n=148) and the LINA prospective birth cohort (n=13) to assess prenatal exposure. Results were further cross-referenced with major epidemiological datasets from Zeilinger et al., Guida et al., and Dogan et al.

Results

The Granulocyte Bias and Cell-Type Specificity

A critical finding of the study is that the vast majority (86.7% to 93.3%) of methylation changes reported in previous whole-blood studies are primarily reflective of changes occurring in granulocytes. The research highlights that epigenetic responses are highly cell-type specific. For instance, the genes GFI1 and F2RL3 exhibited significant hypomethylation in granulocytes (-11.3% and -8.7%, respectively) but remained unaffected in PBMCs.

Venn diagrams showing the overlap of smoking-associated CpG sites (A) and CpG-annotated genes (B) between PBMC and Whole Blood (WB) datasets.

Conversely, changes in the GPR15 gene were found to be exclusive to a specific subset of T-cells. The AHRR gene (specifically CpG site cg05575921) emerged as a "universal" marker, affected in all cell types, though the magnitude varied significantly: a -55.2% methylation change in granulocytes compared to only -15.7% in PBMCs.

Adaptive Immune Expansion

Smoking does not merely alter the DNA of existing T-cells; it appears to trigger the expansion of a specific T-cell population (GPR15+). In smokers, these cells can constitute nearly 40% of the T-cell population, whereas they typically represent less than 10% in non-smokers. This frequency serves as a high-sensitivity biomarker for smoking behavior.

Gene Expression and Stability

Hypomethylation at the AHRR site was found to correlate with increased gene expression—a 2.1-fold increase in granulocytes and a 6.3-fold increase in PBMCs. Regarding the longevity of these marks, while smoking-induced changes in adults are often persistent, the study observed that effects from prenatal exposure in children were transient, typically disappearing within two years of birth.

Discussion

One notable result was the failure of cigarette smoke extract (CSE) to induce hypomethylation in vitro. This suggests that the epigenetic modifications observed in vivo are not the result of a direct chemical interaction with DNA, but rather a consequence of a complex systemic inflammatory response or a broader disruption of homeostasis.

While the study identifies the specific cellular locations of these epigenetic changes, the exact mechanisms remain to be elucidated. Future research is required to determine whether these modifications represent a protective defense mechanism or contribute directly to the pathogenesis of smoking-related conditions such as COPD and lung cancer. Limitations of the current work include the relatively small sample size of the pediatric cohort, which necessitates caution in generalizing the findings regarding the instability of prenatal epigenetic marks.

Summary updated

Abstract

Studying cell type-specific methylation changes provides helpful information regarding the biological relevance of epigenetic modifications. Here, we could show that smoking differently affects both cells of the innate and adaptive immune systems.
BibTeX
@inproceedings{bauer2016tobacco,
  author = {Mario Bauer and Beate Fink and Loreen Thürmann and Markus Eszlinger and Gunda Herberth and Irina Lehmann},
  title = {{Tobacco smoking differently influences cell types of the innate and adaptive immune system—indications from CpG site methylation}},
  booktitle = {Clinical},
  year = {2016},
  doi = {10.1186/s13148-016-0249-7},
}
Figure